Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Notes Payables (2016 - 2024)

Neuroone Medical Technologies' Notes Payables history spans 9 years, with the latest figure at $121896.0 for Q1 2024.

  • For Q1 2024, Notes Payables changed N/A year-over-year to $121896.0; the TTM value through Mar 2024 reached $121896.0, changed N/A, while the annual FY2023 figure was $129116.0, N/A changed from the prior year.
  • Notes Payables reached $121896.0 in Q1 2024 per NMTC's latest filing, down from $129116.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $129116.0 in Q3 2023 to a low of $121896.0 in Q1 2024.